Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
444
-
Total 13F shares, excl. options
-
73.4M
-
Shares change
-
-11.8K
-
Total reported value, excl. options
-
$20.7B
-
Value change
-
-$13.5M
-
Put/Call ratio
-
1.75
-
Number of buys
-
191
-
Number of sells
-
-224
-
Price
-
$282.47
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2014
519 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2014.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 444 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.4M shares
of 105M outstanding shares and own 69.88% of the company stock.
Largest 10 shareholders include Capital World Investors (7.35M shares), WELLINGTON MANAGEMENT CO LLP (5.67M shares), FMR LLC (5.28M shares), SANDS CAPITAL MANAGEMENT, LLC (4.91M shares), VANGUARD GROUP INC (3.91M shares), State Street Corp (3.23M shares), Artisan Partners Limited Partnership (3.19M shares), Viking Global Investors LP (2.96M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.79M shares), and BlackRock Institutional Trust Company, N.A. (2.1M shares).
This table shows the top 444 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.